Investigated event: Influence on protein acticity in presence of TNF

Name Value
Compound Tofacitinib (CP-690.550)
Investigated event Influence on protein acticity in presence of TNF
Experiment type Western Blot
Concentration 1000.00 nM
Cell line FLS
Organism Homo sapiens
Animal model
STAT protein STAT1
Other
Reference
The JAK inhibitor CP-690,550 (tofacitinib) inhibits TNF-induced chemokine expression in fibroblast-like synoviocytes: autocrine role of type I interferon. Annals of the rheumatic diseases Sanna Rosengren, Maripat Corr, Gary S Firestein, David L Boyle, 71, 3, None, 2011-11-25, 10.1136/ard.2011.150284 DOI: 10.1136/ard.2011.150284 PUBMED: 22121136 PMCID: 22121136